Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) -120,000.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 3,257
Avg Vol 216,614
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 79%
Beta N/A
Analysts Strong Sell
Price Target N/A

Company Profile

Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed...

Industry: Biotechnology
Sector: Healthcare
Phone: (650) 800-3717
Address:
4660 La Jolla Village Drive, Suite 100, San Diego, United States
Latest News on REVBW
No data available.